AI Science Tracker
EN

Identification of prognostic signatures in remnant gastric cancer through an interpretable risk model based on machine learning: a multicenter cohort study.

Clinical Oncology School of Fujian Medical University; Fujian Cancer Hospital · 30 Apr 2024 · medicine

Discovery

Identification of prognostic signatures in remnant gastric cancer through an interpretable risk model based on machine learning: a multicenter cohort study.

Source check: Source checked. Not independent scientific confirmation.

Finding: Two hospitals contributed 286 patients, with five-year follow-up; train/validation/test analyses and variable interpretation are reported. An interpretable machine-learning risk model predicts survival in remnant gastric cancer using a multicenter cohort. Testing: Retrospective multicenter cohort; risk estimates are not causal and external validation is still needed.. Source affiliation was not stated in the reviewed case checks and was unavailable in the local bibliographic cache.

Technology: An interpretable machine-learning risk model predicts survival in remnant gastric cancer using a multicenter cohort.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
An interpretable machine-learning risk model predicts survival in remnant gastric cancer using a multicenter cohort.
Test and result
Retrospective multicenter cohort; risk estimates are not causal and external validation is still needed.
Limitation / still unknown
Two hospitals contributed 286 patients, with five-year follow-up; train/validation/test analyses and variable interpretation are reported.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC11062017/unicode · https://europepmc.org/article/MED/38689252

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.